BCM
INO icon

Bridgeway Capital Management’s Inovio Pharmaceuticals INO Stock Holding History

Bridgeway Capital Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$190K Hold
173,000
– – ﹤0.01% 1067
2026
Q1 		$301K Hold
173,000
– – 0.01% 934
2025
Q4 		$301K Buy
+173,000
New +$381K 0.01% 934
2014
Q2 		– Sell
-625
Closed -$100K – 1445
2014
Q1 		$100K Hold
625
– – ﹤0.01% 1386
2013
Q4 		$87K Hold
625
– – ﹤0.01% 1361
2013
Q3 		$62K Buy
+625
New +$52.4K ﹤0.01% 1403

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Bridgeway Capital Management's INO Position: Q2 2026 in Review

Bridgeway Capital Management held its Inovio Pharmaceuticals (INO) position steady in Q2 2026 at 173,000 shares worth $190K. The position accounts for ﹤0.01% of the portfolio, ranked #1067.

Bridgeway Capital Management first reported a position in INO in Q3 2013 and has held it in 6 quarters since. The position peaked at $301K in Q1 2026. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Bridgeway Capital Management held 173,000 shares of Inovio Pharmaceuticals worth $190K as of Q2 2026.
  • Bridgeway Capital Management left its Inovio Pharmaceuticals share count unchanged in Q2 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #1067 holding.
  • Bridgeway Capital Management first reported a position in Inovio Pharmaceuticals in Q3 2013 and has held it in 6 quarters since.
  • Bridgeway Capital Management's Inovio Pharmaceuticals position peaked at $301K in Q1 2026.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.